Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
(Q35553375)
scientific article published on October 2004
scientific article published on October 2004
Language: